Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia. (Q42520807)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia. |
scientific article |
Statements
Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia (English)
Bittencourt AL
Silva-Santos G
Almeida A
Silva AC
Decanine D
Soares GM
Van Dooren S
Galvão-Castro B